Zituvio Tablet
Product Images NDC 70771-1772

6 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvio (NDC 70771-1772). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 04)

Image (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 04)
Chemical structure of sitagliptin, the active ingredient in ZITUVIO, an oral tablet prescription drug by Zydus Lifesciences Limited. The diagram depicts the molecular structure with fluorine atoms, an amino group, and a trifluoromethyl group.*
FDA Label Image

Image (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 05)

Image (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 05)
A line graph showing the least squares mean change from baseline (vertical axis) over a 24-week period (horizontal axis). It compares the effects of different treatments: placebo, Metformin 1000 mg twice daily, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Sitagliptin 50 mg twice daily combined with Metformin 500 mg twice daily, and Sitagliptin 50 mg twice daily combined with Metformin 1000 mg twice daily. Each treatment is represented by a different symbol and line style, depicting the change trajectory over time.*
FDA Label Image

Image (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 06)

Image (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 06)
A line graph showing the LS mean change from baseline over time in weeks, ranging from 0 to 52 weeks. The vertical axis scales the LS mean change from 0.0 to approximately -1.5. Two data series are plotted with different markers, showing a decline until around week 30 followed by a slight increase toward week 52.*
FDA Label Image

25 mg Label (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 01)

25 mg Label (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 01)
The packaging label for ZITUVIO (sitagliptin) tablets 25 mg by Zydus Lifesciences Limited features the product name and strength prominently with a purple and white gradient background. It indicates 90 tablets per package, Rx only, with storage instructions and a caution to dispense the enclosed Medication Guide. The label includes a barcode and manufacturer information from Ahmedabad, India.*
FDA Label Image

50 mg Label (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 02)

50 mg Label (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 02)
Label for ZITUVIO (sitagliptin) Tablets 50 mg oral film-coated tablets, marketed by Zydus Lifesciences Limited. The package contains 90 tablets with prescription-only status. The label includes dosage strength, NDC 70771-1771-9, storage instructions, child-resistant packaging warning, and medication guide dispensing information.*
FDA Label Image

100 mg Label (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 03)

100 mg Label (Bbf5442b 5b0a 40d0 99f4 A6ca809d22b7 03)
Packaging label for Zituvio (Sitagliptin) Tablets 100 mg by Zydus Lifesciences Limited. The label states the product name, strength, dosage form, and contains instructions to dispense the medication guide. It includes storage information and child-resistant packaging details for 90 oral tablets. The label shows the NDC 70771-1772-9 and manufacturer details from Ahmedabad, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.